Just another indication of how antibodies will soon dominate the pharmaceutical market https://www.fiercepharma.com/special-report/top-10...

The antibody-drug conjugate Kadcyla that targets HER2-positive cancer did not have any problems with England's National Health Service...

As I recently posted, Immunomedics had a horrible 2019 with the rejection of their ADC. But 2020 is looking real good. There is no doubt...

Immunomedics finally did it!!!! 2019 was a record year with 3 novel ADCs approved. There was a lot of failures since the last ADC...

I have often wondered how come I don't see an ADC conjugated to two warheads with unique mechanisms of action? At this years AACR meeting...

In this article titled "Chemically triggered drug release from an antibody-drug conjugate leads to potent antitumor activity in mice" the...

In a study sponsored by Genentech titled Anti-NaPi2b antibody-drug conjugate lifastuzumab vedotin (LIFA) compared to pegylated liposomal...

Hello! This months posting I hope you will find interesting because its about Sacituzumab Govitecan (SG) and its impressive clinical...